Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: Prospective multicenter study

Scandinavian Journal of Gastroenterology

Volumn 49, Issue 6, 2014, Pages 674-680

  Fukuba, Nobuhiko ^a   Ishihara, Shunji ^a   Tada, Yasumasa ^a   Oshima, Naoki ^a   Moriyama, Ichiro ^a,b   Yuki, Takafumi ^b   Kawashima, Kousaku ^a,c   Kushiyama, Yoshinori ^d   Fujishiro, Hirofumi ^e   Kinoshita, Yoshikazu ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b SHIMANE UNIVERSITY HOSPITAL   (Japan)

^c Matsue City Hospital   (Japan)

^d MATSUE RED CROSS HOSPITAL   (Japan)

^e SHIMANE PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Clinical remission; Endoscopic remission; IBS like symptoms; Ulcerative colitis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ACTIVITY INDEX; COLONOSCOPY; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOSCOPY; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REMISSION; ULCERATIVE COLITIS; VERY ELDERLY; CASE CONTROL STUDY; CLINICAL TRIAL; COMPLICATION; CONSTIPATION; DIARRHEA; IRRITABLE BOWEL SYNDROME; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLONOSCOPY; CONSTIPATION; DIARRHEA; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84901500683     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.898084     Document Type: Article

References (30)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-91
2. Ishihara S, Yashima K, Kushiyama Y, Izumi A, Kawashima K, Fujishiro H, et al. Prevalence of organic colonic lesions in patients meeting rome III criteria for diagnosis of IBS: A prospective multi-center study utilizing colonoscopy. J Gastroenterol 2012;47:1084-90
3. Grundmann O, Yoon SL. Irritable bowel syndrome: Epidemiology, diagnosis and treatment: An update for health care practitioners. J Gastroenterol Hepatol 2010;25:691-9
4. Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, et al. Guidelines on the irritable bowel syndrome: Mechanisms and practical management. Gut 2007;56: 1770-98. (Pubitemid 350206308
5. Khan S, Chang L. Diagnosis and management of IBS. Nat Rev Gastroenterol Hepatol 2010;7:565-81
6. Öhman L, Simrén M. Pathogenesis of IBS: Role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010;7:163-73
7. Stasi C, Rosselli M, Bellini M, Laffi G, Milani S. Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: The top-down and the bottom-up model. J Gastroenterol 2012;47:1177-85
8. Ahl A, Mikocka-Walus A, Gordon A, Andrews JM. Are self-Administered or minimal therapist contact psychotherapies an effective treatment for irritable bowel syndrome (IBS): A systematic review. J Psychosom Res 2013;75:113-20
9. Ford AC, Talley NJ. Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: A systematic review. J Gastroenterol 2011;46:421-31
10. Ishihara S, Aziz M, Oshima N, Mishima Y, Imaoka H, Moriyama I, et al. Irritable bowel syndrome and inflammatory bowel disease: Infectious gastroenteritis-related disorders?. Clin J Gastroenterol 2009;2:9-16
11. Ishihara S, Tada Y, Fukuba N, Oka A, Kusunoki R, Mishima Y, et al. Pathogenesis of irritable bowel syndrome-review regarding associated infection and immune activation. Digestion 2013;87:204-11
12. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003;124:1662-71. (Pubitemid 36617684
13. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009;136:1979-88
14. Spiller R. Serotonin, inflammation, and IBS: Fitting the jigsaw together?. J Pediatr Gastroenterol Nutr 2007;45: S115-19
15. Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: Systematic review and meta-Analysis. Am J Gastroenterol 2012;107:1474-82
16. Porter CK, Cash BD, Pimentel M, Akinseye A, Riddle MS. Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome. BMC Gastroenterol 2012;12:55
17. Rodriguez LG, Ruigómez A, Wallander M, Johansson S, Olbe L. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol 2000;35:306-11. (Pubitemid 30217185
18. Spiller R, Lam C. The shifting interface between IBS and IBD. Curr Opin Pharmacol 2011;11:586-92
19. Isgar B, Harman M, Kaye M, Whorwell P. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 1983;24:190-2. (Pubitemid 13147731
20. Simrén M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Björnsson ES. Quality of life in inflammatory bowel disease in remission: The impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002;97:389-96. (Pubitemid 34160766
21. Ansari R, Attari F, Razjouyan H, Etemadi A, Amjadi H, Merat S, et al. Ulcerative colitis and irritable bowel syndrome: Relationships with quality of life. Eur J Gastroenterol Hepatol 2008;20:46-50. (Pubitemid 350307488
22. Farrokhyar F, Marshall JK, Easterbrook B, Irvine EJ. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: Prevalence and impact on health. Inflamm Bowel Dis 2006;12: 38-46. (Pubitemid 43032450
23. Minderhoud IM, Oldenburg B, Wismeijer JA. Henegouwen, Gerard P Van Berge, Smout AJ. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 2004;49:469-74. (Pubitemid 38453568
24. Rachmilewitz D. Coated mesalazine (5-Aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial. BMJ 1989;298:82-6. (Pubitemid 19032930
25. Matts SG. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 1961;30:393-407
26. Zallot C, Peyrin-Biroulet L. Deep remission in inflammatory bowel disease: Looking beyond symptoms. Curr Gastroenterol Rep 2013;15:315
27. Hibi T, Sameshima Y, Sekiguchi Y, Hisatome Y, Maruyama F, Moriwaki K, et al. Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: Clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan. Dig Liver Dis 2009;41:570-7
28. Keohane J, O'Mahony C, O'Mahony L, O'Mahony S, Quigley EM, Shanahan F. Irritable bowel syndrome-Type symptoms in patients with inflammatory bowel disease: A real association or reflection of occult inflammation?. Am J Gastroenterol 2010;105:1789-94
29. Guilarte M, Santos J, de Torres I, Alonso C, Vicario M, Ramos L, et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007;56:203-9
30. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002;122: 1778-83. (Pubitemid 34651421